We have now been working carefully with the Authorities of India for the previous 12 months & thank it for its help. We stay dedicated to ramping up our vaccine manufacturing to avoid wasting each life we will,” SII mentioned on Twitter.
The corporate’s response got here after the Well being Ministry in a press release refuted allegations that it has not positioned any contemporary orders for the Covishield vaccine with SII.
The Well being Ministry earlier mentioned that it has paid the whole advance of Rs 1,732.50 crore to SII for 11 crore doses of Covishield vaccine for 3 months — Might, June and July.
The quantity, which after TDS was Rs 1,699.50 crore, was acquired by the SII on April 28 itself, it mentioned.
As on date, in opposition to the final order of 10 crore doses for provides of Covishield vaccine, 8.744 crore doses have been delivered until Might 3, the ministry mentioned, including, media experiences alleging that the Centre has not positioned any contemporary order for COVID-19 vaccines are “incorrect and never based mostly on information”.
Moreover, 100 per cent advance of Rs 787.50 crore (after TDS Rs 772.50 crore) was launched on April 28 to Bharat Biotech India Ltd (BBIL) for 5 crore Covaxin doses throughout Might, June and July. The quantity was acquired by them on April 28.
As on date in opposition to the final order of two crore doses for provides of Covaxin vaccine, 0.8813 crore doses have been delivered until Might 3, the ministry mentioned.
“Therefore, to say that contemporary orders haven’t been positioned by the Authorities of India isn’t appropriate,” it mentioned.
As of Might 2, the Centre has supplied extra 16.54 crore vaccine doses to states and union territories freed from value. Greater than 78 lakh doses are nonetheless accessible with them to be administered, the ministry mentioned.
“Greater than 56 lakh doses, as well as, can be acquired by states and UTs within the subsequent three days,” it acknowledged.
Below the Liberalised Pricing and Accelerated Nationwide COVID-19 Vaccination Technique, the Authorities of India would proceed to acquire its share of fifty per cent of the month-to-month Central Medicine Laboratory (CDL) cleared vaccines and would proceed to make it accessible to the state governments completely freed from value as was being accomplished earlier, the ministry acknowledged.